Abstract
Traditionally the brain has been viewed as being an immune-privileged organ. However, endogenous stimuli such as the presence of misfolded or aggregated proteins, as well as systemic inflammatory events may lead to the activation of microglial cells, the brain´s innate immune system, and, subsequently, to neuroinflammation. Alzheimer's disease, the leading cause of dementia, is characterized by amyloid beta deposition and tau hyperphosphorylation. Neuroinflammation in Alzheimer's disease has been identified as major contributor to disease pathogenesis. Once activated, microglia release several pro and anti-inflammatory mediators of which several affect the function and structure of the brain. Modulation of this microglial activation in Alzheimer's disease might open new therapeutic avenues.
Keywords: Alzheimer's, amyloid-β, cytokines, neuroinflammation, neurodegeneration, microglia.
Related Books
Advances in Alzheimer's Research
Advances in Alzheimer's Research
Recent Advances in Geriatric Medicine
Recent Advances in Geriatric Medicine
Pain: Causes, Concerns and Consequences
Chemical-Induced Seizures: Mechanisms, Consequences and Treatment
Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder
Contemporary Sleep Medicine For Patients
Contemporary Sleep Medicine For Physicians
Experimental Stroke
166
37
1
1
